Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

Obstructive lung diseases like COPD cause trouble when you're exhaling air. Restrictive lung diseases like pulmonary fibrosis make it harder to inhale air, reducing total lung capacity. There are two ...

Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...

In 2021, an estimated 14 million adults in the United States reported a diagnosis of chronic obstructive pulmonary disease (COPD), chronic bronchitis, or emphysema. If you’re not sure what the ...

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require ...

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...